Sign up to save your podcasts
Or
Share Results Are In! Stock Market Reaction to AstraZeneca Oxford Trial Results
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Results Are In! Stock Market Reaction to AstraZeneca Oxford Trial Results
Early reports revealed AstraZeneca's vaccine generates antibodies and T-Cells in the Oxford University phase 1 trial. The official data and results are set to be published today and could have a huge impact on the stock market.
View all episodes
By Dumb Money
4.7
9494 ratings
Early reports revealed AstraZeneca's vaccine generates antibodies and T-Cells in the Oxford University phase 1 trial. The official data and results are set to be published today and could have a huge impact on the stock market.
More shows like Dumb Money Live
View all
Motley Fool Money
3,185 Listeners
Top Traders Unplugged
585 Listeners
We Study Billionaires - The Investor’s Podcast Network
3,372 Listeners
Stansberry Investor Hour
680 Listeners
Animal Spirits Podcast
1,992 Listeners
The Pomp Podcast
1,829 Listeners
Chit Chat Stocks
187 Listeners
The Market Huddle
361 Listeners
Investing With IBD
379 Listeners
The Compound and Friends
2,044 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
8,784 Listeners
RiskReversal Pod
783 Listeners
Forward Guidance
273 Listeners
Bloomberg Talks
14 Listeners
BG2Pod with Brad Gerstner and Bill Gurley
442 Listeners